These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26820365)

  • 1. Targeted resequencing identifies TRPM4 as a major gene predisposing to progressive familial heart block type I.
    Daumy X; Amarouch MY; Lindenbaum P; Bonnaud S; Charpentier E; Bianchi B; Nafzger S; Baron E; Fouchard S; Thollet A; Kyndt F; Barc J; Le Scouarnec S; Makita N; Le Marec H; Dina C; Gourraud JB; Probst V; Abriel H; Redon R; Schott JJ
    Int J Cardiol; 2016 Mar; 207():349-58. PubMed ID: 26820365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of
    Palladino A; Papa AA; Petillo R; Scutifero M; Morra S; Passamano L; Nigro V; Politano L
    Genes (Basel); 2022 Jan; 13(2):. PubMed ID: 35205305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient receptor potential melastatin 4 cation channel in pediatric heart block.
    Tian J; An XJ; Fu MY
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(4 Suppl):79-84. PubMed ID: 29165759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired endocytosis of the ion channel TRPM4 is associated with human progressive familial heart block type I.
    Kruse M; Schulze-Bahr E; Corfield V; Beckmann A; Stallmeyer B; Kurtbay G; Ohmert I; Schulze-Bahr E; Brink P; Pongs O
    J Clin Invest; 2009 Sep; 119(9):2737-44. PubMed ID: 19726882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational spectrum in the Ca(2+)--activated cation channel gene TRPM4 in patients with cardiac conductance disturbances.
    Stallmeyer B; Zumhagen S; Denjoy I; Duthoit G; Hébert JL; Ferrer X; Maugenre S; Schmitz W; Kirchhefer U; Schulze-Bahr E; Guicheney P; Schulze-Bahr E
    Hum Mutat; 2012 Jan; 33(1):109-17. PubMed ID: 21887725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variants of Transient Receptor Potential Melastatin Member 4 in Childhood Atrioventricular Block.
    Syam N; Chatel S; Ozhathil LC; Sottas V; Rougier JS; Baruteau A; Baron E; Amarouch MY; Daumy X; Probst V; Schott JJ; Abriel H
    J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27207958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gain-of-function mutations in TRPM4 cause autosomal dominant isolated cardiac conduction disease.
    Liu H; El Zein L; Kruse M; Guinamard R; Beckmann A; Bozio A; Kurtbay G; Mégarbané A; Ohmert I; Blaysat G; Villain E; Pongs O; Bouvagnet P
    Circ Cardiovasc Genet; 2010 Aug; 3(4):374-85. PubMed ID: 20562447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional characterization of TRPM4 variants identified in sudden unexpected natural death.
    Subbotina E; Williams N; Sampson BA; Tang Y; Coetzee WA
    Forensic Sci Int; 2018 Dec; 293():37-46. PubMed ID: 30391667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole exome sequencing identified a pathogenic nonsense mutation in LMNA in a family with a progressive cardiac conduction defect: A case report.
    Fan P; Zhang D; Yang KQ; Tian T; Luo F; Liu YX; Wang LP; Zhou XL
    Mol Med Rep; 2020 Jun; 21(6):2459-2465. PubMed ID: 32323820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRPM4 channels in the cardiovascular system.
    Kruse M; Pongs O
    Curr Opin Pharmacol; 2014 Apr; 15():68-73. PubMed ID: 24721656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mutation screening for the causative gene in a four-generation Chinese pedigree with progressive cardiac conduction defect].
    Tan XJ; Huang H; He F; Zhu L; Li H; Jiang YS; Li H; Huang XH; Sun ZS; Li ZH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 May; 44(5):411-5. PubMed ID: 27220576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant Deactivation-Induced Gain of Function in TRPM4 Mutant Is Associated with Human Cardiac Conduction Block.
    Xian W; Hui X; Tian Q; Wang H; Moretti A; Laugwitz KL; Flockerzi V; Ruppenthal S; Lipp P
    Cell Rep; 2018 Jul; 24(3):724-731. PubMed ID: 30021168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A connexin40 mutation associated with a malignant variant of progressive familial heart block type I.
    Makita N; Seki A; Sumitomo N; Chkourko H; Fukuhara S; Watanabe H; Shimizu W; Bezzina CR; Hasdemir C; Mugishima H; Makiyama T; Baruteau A; Baron E; Horie M; Hagiwara N; Wilde AA; Probst V; Le Marec H; Roden DM; Mochizuki N; Schott JJ; Delmar M
    Circ Arrhythm Electrophysiol; 2012 Feb; 5(1):163-72. PubMed ID: 22247482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a strong genetic background for progressive cardiac conduction defect by epidemiological approach.
    Gourraud JB; Kyndt F; Fouchard S; Rendu E; Jaafar P; Gully C; Gacem K; Dupuis JM; Longueville A; Baron E; Karakachoff M; Cebron JP; Chatel S; Schott JJ; Le Marec H; Probst V
    Heart; 2012 Sep; 98(17):1305-10. PubMed ID: 22717692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inherited progressive cardiac conduction disorders.
    Baruteau AE; Probst V; Abriel H
    Curr Opin Cardiol; 2015 Jan; 30(1):33-9. PubMed ID: 25426816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preprodynorphin gene mutation causes progressive cardiac conduction disease: A whole-exome analysis of a pedigree.
    Su JY; Zhang RF; Dong YX; Yang MH; Yin XM; Gao LJ; Li HH; Xia YL; Yang YZ
    Life Sci; 2019 Feb; 219():74-81. PubMed ID: 30611784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical, single-channel, whole-cell patch clamp, and pharmacological analyses of endogenous TRPM4 channels in HEK293 cells.
    Amarouch MY; Syam N; Abriel H
    Neurosci Lett; 2013 Apr; 541():105-10. PubMed ID: 23428507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theoretical Investigation of the Mechanism by which A Gain-of-Function Mutation of the TRPM4 Channel Causes Conduction Block.
    Hu Y; Li Q; Shen Y; Fujita T; Zhu X; Inoue R
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A newly identified missense mutation in CLCA2 is associated with autosomal dominant cardiac conduction block.
    Mao Z; Wang Y; Peng H; He F; Zhu L; Huang H; Huang X; Lu X; Tan X
    Gene; 2019 Sep; 714():143990. PubMed ID: 31326550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-Exome Sequencing Identifies a Novel
    Dong Y; Du R; Fan LL; Jin JY; Huang H; Chen YQ; Bi DD; Xiang R
    Biomed Res Int; 2021; 2021():9247541. PubMed ID: 33959666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.